TwitterRSSFacebookDirectors Blog
  Disorders A - Z:   A    B   C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z

Skip secondary menu

NINDS Neuroscience Funding Announcements



Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders

Funding Contact(s): Debra Babcock, MD., Ph.D.
Funding Categories: Systems and Cognitive Neuroscience

Brief Description:

This Funding Opportunity Announcement (FOA) issued by the National Institute of Mental Health (NIMH), the National Institute on Aging (NIA), the National Institute of Alcohol Abuse and Alcoholism (NIAAA), the National Institute of Biomedical Imaging and Bioengineering (NIBIB), and the National Institute on Drug Abuse (NIDA) of the National Institutes of Health (NIH), invites NIH Exploratory/Developmental Grant (R21) applications from organizations/institutions that propose the development of novel radioligands for positron emission tomography (PET) or single photon emission computed tomography (SPECT) imaging in human brain, and that incorporate pilot or clinical feasibility evaluation in pre-clinical studies, model development, or clinical studies.



Grant Mechanism: R21
NIH Guide: PA-06-461
Release Date: 2006-08-07
Expiration Date: 2009-09-08

Grant Mechanism: R33
NIH Guide: PA-06-462
Expiration Date: 2009-09-08